Latham & Watkins advised the lead investor on its Series C investment in Oviva, a health tech startup. Oviva’s US$80 million Series C funding brings its total raised to date to US$115 million.
Oviva combines expert advice from dietitians with digital tools to help people with conditions such as type 2 diabetes improve their health. Oviva will use the new capital to scale up its business.
The Latham team was led by London partner Mike Turner and associate Samantha Si.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
